New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
14:09 EDTESALYEisai carcinoma treatment granted FDA orphan designation
According to a post on the FDA's website, Eisai's lenvatinib for the treatment of hepatocellular carcinoma has been granted orphan designation. Reference Link
News For ESALY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 10, 2014
11:38 EDTESALYArena, Eisai announce publication of BELVIQ Phase 3 trial
Subscribe for More Information
10:38 EDTESALYFDA approves Eisai drug to treat nausea in chemo patients
The FDA said it approved Akynzeo to treat nausea and vomiting in patients undergoing cancer chemotherapy. Akynzeo is distributed and marketed by Eisai.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use